Glut1 mesothelioma
WebGLUT-1 is expressed in many human tissues including those of the colon, lung, stomach, esophagus and breast. Overexpression of GLUT1 is associated with aggressive behavior … WebJan 1, 2014 · The global incidence of malignant mesothelioma (MM), an aggressive tumor of the serosal surface, is increasing. 1 Although a multimodality therapeutic approach …
Glut1 mesothelioma
Did you know?
WebJan 4, 2009 · Immunohistochemical analysis has been extensively applied as an aid in the distinction between malignant mesothelioma (MM) and other tumors that can ... EMA is … WebJul 1, 2012 · Context.—Malignant mesothelioma, of either peritoneum or pleura, is an uncommon cancer. The diagnosis is often difficult to make, in part because of the overlapping morphology of reactive and malignant …
WebNational Center for Biotechnology Information WebAbstract. Background: Previous studies have demonstrated the diagnostic value of glucose transporter 1 (GLUT-1) to distinguish malignant mesothelioma (MM) from reactive mesothelial cells (RMC), but the results are inconsistent. The purpose of this meta …
WebMar 5, 2010 · The distinction between reactive mesothelial hyperplasia (MH) and malignant mesothelioma (MM) may be very difficult based only on histologic and morphologic findings; of 217 cases circulated among all members of the US-Canadian Mesothelioma Reference Panel, there was some disagreement about whether the process was benign … WebApr 10, 2024 · GLUT1 was essential for the maintenance of pancreatic, ovarian, and glioblastoma CSCs, and a specific GLUT1 inhibitor inhibited the functionality of CSCs and, in vivo, it delayed tumor initiation after the implantation of CSCs . Similar observations were reported for MCF-10A cells, a commonly used human mammary epithelial cell line for the ...
WebJul 2, 2024 · July 2, 2024 By Thomas Lamb. Background: Malignant peritoneal mesothelioma is the most common primary peritoneal neoplasm. The only universally recognised pathological prognostic factor is histopathological subtype. Prognostic markers based on patient features and clinical stages have been disappointing. Aims: To assess …
WebBackground: Previous studies have demonstrated the diagnostic value of glucose transporter 1 (GLUT-1) to distinguish malignant mesothelioma (MM) from reactive … raiba schwabmünchen online banking loginWebFeb 1, 2007 · However, immunoreactive cells more than half of tumor cell was only 16 of 47 (34%) of epithelioid mesothelioma including epithelioid areas of biphasic mesothelioma, and two of 12 (14.1%) of sarcomatoid mesothelioma including sarcomatoid areas of biphasic mesothelioma. The GLUT-1-positive cells varied from a few cells to almost all … raiba sommerachWebJan 9, 2024 · The reactivity of GLUT1 showed a significant difference (P<0.01) between mesothelioma and reactive mesothelium.Conclusions:The optimal combination is a … raiba schwabach rothWebJun 28, 2014 · Malignant mesothelioma (MM) is the aggressive tumor of serosal surfaces. There are crude pathogenetic results regarding the biology of MM. Coordinated … raiba seenplatte warenWebMar 1, 2014 · GLUT-1 expression is undetectable in most normal epithelia and benign epithelial tumors, and its expression has been shown to indicate epithelial malignancy in a variety of organs [18], [19], [20]. Despite the first report showing GLUT-1 positivity in all mesothelioma cases (48/48), subsequent studies have had varied success [2], [10], [21 ... raiba sonnenwald plattlingWebJun 8, 2024 · GLUT1 is a member of the glucose transporter isoform family and facilitates the entry of glucose into cells. 32 Hommell-Fontaine et al. revealed that GLUT1 … raiba simmerath loginWebGLUT1 antibody is expressed at variable levels in many human tissues. Overexpression of GLUT1 has been linked to tumor progression or poor survival of patients with carcinomas of the colon, breast, cervix, lung, bladder and mesothelioma. It can be used to distinguish between malignant mesothelioma (positve) from reactive mesothelium (negative). raiba sonthofen blz